Vir Biotechnology (VIR) News Today → The ONE AI Stock to own now. (It’s not Nvidia.) (From Weiss Ratings) (Ad) Free VIR Stock Alerts $9.56 +0.02 (+0.21%) (As of 05/9/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineResearch Analysts Offer Predictions for Vir Biotechnology, Inc.'s FY2024 Earnings (NASDAQ:VIR)marketbeat.com - May 9 at 7:13 AMHC Wainwright Reiterates Buy Rating for Vir Biotechnology (NASDAQ:VIR)americanbankingnews.com - May 9 at 4:28 AMAnalysts Just Shipped A Stunning Upgrade To Their Vir Biotechnology, Inc. (NASDAQ:VIR) Estimatesfinance.yahoo.com - May 8 at 7:18 AMBuy Rating Affirmed: Anticipated Breakthroughs in Vir Biotechnology’s Clinical Pipelinemarkets.businessinsider.com - May 7 at 4:14 PMDeep Dive Into Vir Biotechnology Stock: Analyst Perspectives (6 Ratings)markets.businessinsider.com - May 7 at 11:13 AMVir Biotechnology (NASDAQ:VIR) Receives Buy Rating from HC Wainwrightmarketbeat.com - May 7 at 8:09 AMVir Biotechnology (NASDAQ:VIR) PT Raised to $12.00americanbankingnews.com - May 5 at 5:46 AMVir Biotechnology (NASDAQ:VIR) Stock Rating Reaffirmed by Needham & Company LLCamericanbankingnews.com - May 5 at 5:46 AMBuy Rating Affirmed for Vir Biotechnology Amid Promising HDV and HBV Treatment Milestonesmarkets.businessinsider.com - May 4 at 4:45 PMVir Biotechnology, Inc. (NASDAQ:VIR) Given Average Rating of "Moderate Buy" by Analystsamericanbankingnews.com - May 4 at 2:40 AMVir Biotechnology (NASDAQ:VIR) Shares Gap Up on Better-Than-Expected Earningsamericanbankingnews.com - May 4 at 2:04 AMVir Biotechnology (NASDAQ:VIR) Announces Quarterly Earnings Resultsmarketbeat.com - May 3 at 9:54 PMVir Biotechnology's (VIR) "Buy" Rating Reaffirmed at Needham & Company LLCmarketbeat.com - May 3 at 9:51 PMVir Biotechnology (NASDAQ:VIR) Price Target Raised to $12.00marketbeat.com - May 3 at 9:51 PMHold Rating on Vir Biotechnology Amid Financial Concerns and Clinical Trial Uncertaintymarkets.businessinsider.com - May 3 at 9:28 PMVir Biotechnology, Inc. (NASDAQ:VIR) Q1 2024 Earnings Call Transcriptfinance.yahoo.com - May 3 at 9:28 PMVir Biotechnology (NASDAQ:VIR) Shares Gap Up on Strong Earningsmarketbeat.com - May 3 at 12:54 PMVir Biotechnology Provides Some Hope For Its Beleaguered Shareholdersseekingalpha.com - May 3 at 12:47 PMVir Biotechnology Inc (VIR) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...finance.yahoo.com - May 3 at 8:17 AMQ1 2024 Vir Biotechnology Inc Earnings Callfinance.yahoo.com - May 3 at 8:17 AMVIR Stock Earnings: Vir Biotechnology Beats EPS for Q1 2024investorplace.com - May 2 at 10:03 PMVir Biotechnology GAAP EPS of -$0.48 beats by $0.59, revenue of $56.38M beats by $44.67Mmsn.com - May 2 at 5:54 PMVir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial Resultsbusinesswire.com - May 2 at 4:05 PMVir Biotechnology earnings preview: what Wall Street is expectingmarkets.businessinsider.com - May 1 at 5:31 PMVir Biotechnology to Participate in the BofA Securities Healthcare Conference 2024finance.yahoo.com - April 30 at 7:30 PMWith 53% ownership, Vir Biotechnology, Inc. (NASDAQ:VIR) boasts of strong institutional backingfinance.yahoo.com - April 28 at 10:13 AMVir Biotechnology (NASDAQ:VIR) Trading 7.6% Higher marketbeat.com - April 26 at 8:10 PMSouthern policies help level up investment from East Asiamsn.com - April 26 at 2:05 AMVir Biotechnology (NASDAQ:VIR) Hits New 52-Week Low at $7.65marketbeat.com - April 25 at 3:44 PMMirae Asset Global Investments Co. Ltd. Purchases 155,196 Shares of Vir Biotechnology, Inc. (NASDAQ:VIR)marketbeat.com - April 20 at 4:54 AMVir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its Board of Directorsfinance.yahoo.com - April 18 at 12:56 PMVir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D.businesswire.com - April 18 at 8:00 AMVir Biotechnology Incmorningstar.com - April 16 at 7:43 AMVir Biotechnology to Provide Business Update and Report First Quarter 2024 Financial Results on May 2, 2024finance.yahoo.com - April 11 at 6:02 PMVir Biotechnology to Provide Business Update and Report First Quarter 2024 Financial Results on May 2, 2024businesswire.com - April 11 at 4:30 PMVir Biotechnology, Inc. (NASDAQ:VIR) Given Average Recommendation of "Moderate Buy" by Brokeragesmarketbeat.com - April 9 at 2:46 AMInsider Selling: Vir Biotechnology, Inc. (NASDAQ:VIR) CEO Sells 72,995 Shares of Stockinsidertrades.com - April 5 at 7:30 AMVanguard Group Inc. Boosts Holdings in Vir Biotechnology, Inc. (NASDAQ:VIR)marketbeat.com - April 5 at 4:06 AMVir Biotechnology Inc CEO Backer De Sells 72,995 Sharesfinance.yahoo.com - April 4 at 8:20 PMVir Biotechnology, Inc. (NASDAQ:VIR) CEO Sells $690,532.70 in Stockmarketbeat.com - April 4 at 7:07 PMVir Biotechnology, Inc. (NASDAQ:VIR) EVP Sells $27,245.55 in Stockinsidertrades.com - April 3 at 5:38 AMVir Biotechnology, Inc. (NASDAQ:VIR) EVP Ann M. Hanly Sells 2,711 Sharesmarketbeat.com - April 3 at 12:15 AMInsider Selling: Vir Biotechnology, Inc. (NASDAQ:VIR) CFO Sells 6,008 Shares of Stockinsidertrades.com - March 29 at 8:56 AMSung Lee Sells 6,008 Shares of Vir Biotechnology, Inc. (NASDAQ:VIR) Stockmarketbeat.com - March 28 at 3:38 PMBillionaire’s Biotech Bets: 3 Stocks Dominating Bill Gates’ Portfoliofinance.yahoo.com - March 21 at 2:10 AMVir Biotechnology (NASDAQ:VIR) Trading Down 4.8%marketbeat.com - March 19 at 3:33 PMFrom Six Figures to Seven: 3 Biotech Stocks Set to Make Millionairesinvestorplace.com - March 19 at 2:58 PMVir Biotechnology (NASDAQ:VIR) Stock Rating Reaffirmed by HC Wainwrightmarketbeat.com - March 18 at 6:32 PMHudson Bay Capital Management LP Buys 197,500 Shares of Vir Biotechnology, Inc. (NASDAQ:VIR)marketbeat.com - March 17 at 5:11 AMVIR Jul 2024 17.500 callca.finance.yahoo.com - March 16 at 7:21 AM Get Vir Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for VIR and its competitors with MarketBeat's FREE daily newsletter. Email Address The ONE AI Stock to own now. (It’s not Nvidia.) (Ad)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made … Click here to see the presentation now. VIR Media Mentions By Week VIR Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VIR News Sentiment▼0.640.43▲Average Medical News Sentiment VIR News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VIR Articles This Week▼264▲VIR Articles Average Week Get Vir Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for VIR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: INVA News RLAY News CVAC News BEAM News CDMO News ALLO News TWST News FATE News REPL News BLUE News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VIR) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe Crypto 9-5 Escape PlanCrypto 101 MediaObama’s Forever Term [exposed]Porter & CompanyForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vir Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
